CompletedPhase 2NCT00530075

Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis

Studying Vasculitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nippon Kayaku Co., Ltd.
Principal Investigator
David Jayne, MD
Cambridge University Hospitals NHS Foundation Trust
Intervention
Gusperimus(drug)
Enrollment
45 enrolled
Eligibility
18-80 years · All sexes
Timeline
20032006

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00530075 on ClinicalTrials.gov

Other trials for Vasculitis

Additional recruiting or active studies for the same condition.

See all trials for Vasculitis

← Back to all trials